Bluejay Diagnostics (BJDX) Enterprise Value (2022 - 2023)
Bluejay Diagnostics (BJDX) has disclosed Enterprise Value for 2 consecutive years, with -$5.1 million as the latest value for Q3 2023.
- Quarterly Enterprise Value rose 61.8% to -$5.1 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$5.1 million through Sep 2023, up 61.8% year-over-year, with the annual reading at -$10.1 million for FY2022, N/A changed from the prior year.
- Enterprise Value hit -$5.1 million in Q3 2023 for Bluejay Diagnostics, roughly flat from -$5.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.1 million in Q3 2023 to a low of -$17.1 million in Q1 2022.